The US pharmaceutical landscape is in the midst of impactful shifts

A series of ambitious, aggressive, and often interconnected federal policy changes—from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches—is creating a new reality for industry leaders, innovators, and strategists.

In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.

Key Features

• Understand the Interconnectedness of U.S. Federal Policies.
• Analyze the Strategic Impacts of Key Legislation and Executive Actions.
• Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.
• Analyze the Interplay of U.S. Federal Actions and Industry Operations.
• Formulate Adaptive Strategies for Industry Resilience.